Three of the largest manufacturers of the common antibiotic amoxicillin are reporting supply concerns.
Hikma Pharmaceuticals, Teva Pharmaceutical Industries and Sandoz, the generics division of Novartis, have all reported shortages of various doses of the drug, which is most commonly used to treat bacterial infections in children.
Amoxicillin comes as a capsule, a tablet, a chewable tablet and as a liquid to be taken by mouth, depending on the age of the patient.
Most of the shortages were reported in the liquid form of the drug, which is used by young children, according to the University of Utah’s drug information service, which tracks medication shortages, though the database shows the companies reported limited supply of all the versions of the drug.
As of Oct. 25, the university’s drug tracker listed 14 of Hikma Pharmaceuticals’ amoxicillin products and nine products from Teva. The tracker listed 16 products from Sandoz as being in shortage.
The most common reason antibiotics are prescribed for children is to treat ear infections, though they can also be used to treat bacterial sinus and throat infections. According to the Centers for Disease Control and Prevention, amoxicillin is considered a “first-line” therapy, though there are other antibiotics that can be used.
A Food and Drug Administration (FDA) spokesman said the agency was aware “of some intermittent supply interruptions of amoxicillin products in the U.S, and are currently working with the approved manufacturers.”
However, the FDA doesn’t consider amoxicillin to be in shortage because at least one manufacturer is able to fully supply market demand.
Hikma spokesman Steve Weiss said amoxicillin is on allocation, meaning the company has enough supply to fulfill the orders of current customers, but is limiting new orders.
“We are managing distribution to make sure we continue to fully meet our existing supply commitments,” Weiss said. “Our number one priority is to honor the commitments we have to our current customers and allocation allows us to achieve this.”
Leslie Pott, spokeswoman for Sandoz, said there is a “significant demand uptake”
“The combination in rapid succession of the pandemic impact and consequent demand swings, manufacturing capacity constraints, scarcity of raw materials, and the current energy crisis means we currently face a uniquely difficult situation,” Pott said.
She said Sandoz is on track to “strengthen the supply reliability of our antibiotics currently low in stock.”
It's VERY common here for German ancestry to be denied. Especially Trump's generation. Despite the fact that German was almost our FIRST official language. It lost by ONE vote.
Even now, with politicians, they legally change their name from German to something else. You would be amazed, how many have changed their sir name . Usually Italian for some reason, especially if they want office on the East Coast (New Yorkers). Maybe in the South, they go with French.
YIKES I am not happy with him being 1st generation born. I wouldn't be comfortable with that here either; though it's legal here, I think But it doesn't matter what I think about it there or here
After all the American bashing I / we have seen in the last 7 yrs in International. Did you somehow take my posting UK journalists personal? I don't bash the UK. Hell I worry about it I'm one of the few, who have posted GOD SAVE THE QUEEN, especially to this OP
BTW: I do post about Biden polls. I will post negative or the truth about ANY political figure in any country
Have a good day and good luck with social credit and finding the UK forum
Aww.... You put down your drink Bro and slittered out of woodwork, just for me. again
While you are here and almost coherent..... We are still waiting on all those, "How wonderful life is with Biden" & "How much safer the world is with Biden" and "How he is globally respected"
Renewed threat of #railstrike has supply chain managers ramping up contingency plans
Brotherhood of Maintenance of Way Employees Division of the International Brotherhood of Teamsters (BMWED), the third-largest rail union, rejected a labor deal with railroads that the Biden Administration had helped to negotiate. Unions are able to strike starting on Nov.19 unless Congress intervenes or a deal is reached. A union rep told CNBC, "The railroads consistently underestimate the frustration and anger of the workers. Workers can't take it anymore."
Logistics managers are dusting off their plans for a possible railroad strike in November that could wreak havoc on the supply chain and cost the U.S. economy up to $2 billion a day.
Maybe they will take all those trannies, who want to have "storytime" with 5 year olds ... For the front lines. I'm sure Russia, China, Iran and North Korea will be more than happy to greet them
UK Defense Secretary Ben Wallace takes "emergency trip" to US amid Nuclear war fears
Ugh .. any minute now, MSM / political figures, will be crying... "We must defend Europe, we must defend our allies, we must stick to the clause in the treaty. Blah blah blah...
Send those 29 other countries. We are busy over here and tired of paying with our lives and purses
October Surprise 2022
Shortages of antibiotic AmoxicillinThree of the largest manufacturers of the common antibiotic amoxicillin are reporting supply concerns.
Hikma Pharmaceuticals, Teva Pharmaceutical Industries and Sandoz, the generics division of Novartis, have all reported shortages of various doses of the drug, which is most commonly used to treat bacterial infections in children.
Amoxicillin comes as a capsule, a tablet, a chewable tablet and as a liquid to be taken by mouth, depending on the age of the patient.
Most of the shortages were reported in the liquid form of the drug, which is used by young children, according to the University of Utah’s drug information service, which tracks medication shortages, though the database shows the companies reported limited supply of all the versions of the drug.
As of Oct. 25, the university’s drug tracker listed 14 of Hikma Pharmaceuticals’ amoxicillin products and nine products from Teva. The tracker listed 16 products from Sandoz as being in shortage.
The most common reason antibiotics are prescribed for children is to treat ear infections, though they can also be used to treat bacterial sinus and throat infections. According to the Centers for Disease Control and Prevention, amoxicillin is considered a “first-line” therapy, though there are other antibiotics that can be used.
A Food and Drug Administration (FDA) spokesman said the agency was aware “of some intermittent supply interruptions of amoxicillin products in the U.S, and are currently working with the approved manufacturers.”
However, the FDA doesn’t consider amoxicillin to be in shortage because at least one manufacturer is able to fully supply market demand.
Hikma spokesman Steve Weiss said amoxicillin is on allocation, meaning the company has enough supply to fulfill the orders of current customers, but is limiting new orders.
“We are managing distribution to make sure we continue to fully meet our existing supply commitments,” Weiss said. “Our number one priority is to honor the commitments we have to our current customers and allocation allows us to achieve this.”
Leslie Pott, spokeswoman for Sandoz, said there is a “significant demand uptake”
“The combination in rapid succession of the pandemic impact and consequent demand swings, manufacturing capacity constraints, scarcity of raw materials, and the current energy crisis means we currently face a uniquely difficult situation,” Pott said.
She said Sandoz is on track to “strengthen the supply reliability of our antibiotics currently low in stock.”
Teva didn’t respond to a request for comment.